Codexis Inc (CDXS)
3.815
+0.32
(+9.31%)
USD |
NASDAQ |
Nov 05, 16:00
3.82
0.00 (0.00%)
After-Hours: 18:13
Codexis Total Liabilities (Quarterly): 74.78M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 74.78M |
| June 30, 2024 | 70.56M |
| March 31, 2024 | 70.29M |
| December 31, 2023 | 49.95M |
| September 30, 2023 | 62.95M |
| June 30, 2023 | 82.63M |
| March 31, 2023 | 92.05M |
| December 31, 2022 | 105.60M |
| September 30, 2022 | 81.16M |
| June 30, 2022 | 75.51M |
| March 31, 2022 | 76.64M |
| December 31, 2021 | 81.99M |
| September 30, 2021 | 58.50M |
| June 30, 2021 | 49.54M |
| March 31, 2021 | 48.43M |
| December 31, 2020 | 51.54M |
| September 30, 2020 | 47.22M |
| June 30, 2020 | 47.00M |
| March 31, 2020 | 50.41M |
| December 31, 2019 | 43.56M |
| September 30, 2019 | 43.69M |
| June 30, 2019 | 48.11M |
| March 31, 2019 | 49.91M |
| December 31, 2018 | 22.98M |
| September 30, 2018 | 23.83M |
| Date | Value |
|---|---|
| June 30, 2018 | 23.43M |
| March 31, 2018 | 29.44M |
| December 31, 2017 | 29.08M |
| September 30, 2017 | 22.01M |
| June 30, 2017 | 19.15M |
| March 31, 2017 | 18.95M |
| December 31, 2016 | 16.55M |
| September 30, 2016 | 15.67M |
| June 30, 2016 | 17.18M |
| March 31, 2016 | 23.08M |
| December 31, 2015 | 21.77M |
| September 30, 2015 | 21.03M |
| June 30, 2015 | 18.19M |
| March 31, 2015 | 19.80M |
| December 31, 2014 | 21.81M |
| September 30, 2014 | 19.58M |
| June 30, 2014 | 15.92M |
| March 31, 2014 | 19.39M |
| December 31, 2013 | 17.36M |
| September 30, 2013 | 15.56M |
| June 30, 2013 | 16.14M |
| March 31, 2013 | 22.90M |
| December 31, 2012 | 21.52M |
| September 30, 2012 | 26.04M |
| June 30, 2012 | 25.16M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
43.56M
Minimum
Dec 2019
105.60M
Maximum
Dec 2022
66.01M
Average
66.62M
Median
Total Liabilities (Quarterly) Benchmarks
| Rhythm Pharmaceuticals Inc | 202.35M |
| Allogene Therapeutics Inc | 131.84M |
| Maravai LifeSciences Holdings Inc | 671.19M |
| Artiva Biotherapeutics Inc | 264.83M |
| CEL-SCI Corp | 15.60M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 148.18M |
| Shareholders Equity (Quarterly) | 73.40M |
| Debt to Equity Ratio | 0.3901 |
| Current Ratio | 3.214 |
| Net Debt Paydown Yield | -2.28% |